Redefining Contraceptive Care

WHAT WE DO

We are a women-led startup creating a new female birth control solution designed to be long acting and side effect free

THE STANDARD OF BIRTH CONTROL TODAY

The birth control pill was developed in the 1950s.

IUDs were first introduced in the 1800s. The copper IUD was FDA approved in 1984.

The birth control pill was FDA approved in 1960. All hormone-based methods use the same mechanisms of action as “the pill,” and they can have the same side effects.

Half of pregnancies are unplanned.

30% of all maternal deaths result from unplanned pregnancies.

In 2010, the US government spent $21 billion on the births, abortions, and miscarriages that resulted from unplanned pregnancies.

Every highly effective birth control option can cause side effects.

All highly effective and reversible methods use hormones or copper.

Hormones and copper can cause cause unwanted or adverse side effects.

50% of women stop using their birth control because they are unhappy with or cannot tolerate the side effects.

Existing birth control methods do not meet the needs of all women

We’re pioneering a new class of contraception

Our Technology

A birth control device for women that is highly effective, hormone-free, and copper-free

Our Mission

To offer a more acceptable and affordable birth control option for women to help them gain full control over their family planning

Supported By

Recent Updates

  • Women's Health Innovation Summit

    September 2024 | Boston, MA

    Our CEO pitched and won the prestigious Innovation Showcase award for the Therapeutic, Diagnostic, and Medical Device category at this year’s Women’s Health Innovation Summit.

  • Reproductive Health Innovation Summit

    February 2024 | Boston, MA

    Our CEO presented on panel, “A New Age for Contraception? Opportunities to Improve the Benchmark Beyond Innovation” with the NIH, the Bill & Melinda Gates Foundation, and RH Capital.

  • National Contraception Meeting

    November 2023 | Houston, TX

    Our CEO and Chief Medical Advisor presented updates on ongoing NICHD-funded projects at the annual contraceptive development meeting at Baylor College of Medicine.

  • The Life Sciences Eddie Award

    November 2023 | Boston, MA

    Venova Technologies was awarded the first place 2023 Life Sciences Eddie Award (formerly New England Innovation Award) from the Massachusetts Innovation Network.

  • LabCentral Ignite Golden Ticket Award

    September 2023 | Cambridge, MA

    Venova Technologies was awarded a LabCentral Ignite Golden Ticket, providing support and lab space to founders who are underrepresented in biotech.

An underserved market with high upside potential

Offering a highly effective, long acting, and side-effect-free birth control option will give hundreds of millions of women and pregnancy capable people more autonomy over their health, leading to healthier families and more prosperous societies.